Adverse Adolescent Pathways to Substance Use

Description

Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxiety and their legal caregiver will be recruited from clinical and community sources. Procedures: Youth participants will complete several questionnaires and interviews, undergo neuroimaging while performing cognitive tasks, and have their heart rate and skin conductance monitored during a mildly stressful task. Caregivers will complete several questionnaires.

Conditions

Anxiety, Adolescent Development, Substance Use

Talk to us

Study Overview

On this page

Study Details

Study overview

Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxiety and their legal caregiver will be recruited from clinical and community sources. Procedures: Youth participants will complete several questionnaires and interviews, undergo neuroimaging while performing cognitive tasks, and have their heart rate and skin conductance monitored during a mildly stressful task. Caregivers will complete several questionnaires.

Adverse Adolescent Pathways to Substance Use

Adverse Adolescent Pathways to Substance Use

Condition
Anxiety
Intervention / Treatment

-

Contacts and Locations

Chapel Hill

The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States, 27599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or female
  • * 12-14 years old,
  • * Report symptoms of anxiety
  • * Understand and sign an assent, and parents will sign a permission and a consent document in English
  • * Meets study hearing and vision requirements
  • * Substance use naïve
  • * Has any foreign metal objects or implants as determined by the safety questionnaires (e.g., bone screws, shunts or body piercing that can't be removed, etc.)
  • * Has been diagnosed with psychosis or a severe emotional disturbance.
  • * Has used alcohol, tobacco, or marijuana more than 3 times.
  • * Is pregnant. Girls who self-report pregnancy may not participate in the stress evaluation or the MRI scan.
  • * Is taking any medications that directly alter cardiovascular function (e.g., propranolol or other beta blockers).
  • * Any current or lifetime treatment with antipsychotic medication.
  • * Has had a head injury that resulted in a loss of consciousness for more than 5 minutes.
  • * Is planning to get non-removable metal braces.
  • * Impaired intellectual functioning (full-scale intelligence quotient \<70).
  • * Past or current history of a clinically significant central nervous system that could confound brain imaging evaluations.

Ages Eligible for Study

12 Years to 14 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of North Carolina, Chapel Hill,

Aysenil Belger, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

2030-06-30